Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Malgorzata K Tuxen; Soeren Cold; Ulla B Tange; Eva Balslev; Dorte L Nielsen

doi:10.3109/0284186X.2014.921727

Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Malgorzata K Tuxen, Soeren Cold, Ulla B Tange, Eva Balslev, Dorte L Nielsen

Institut for Klinisk Medicin

10 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Acta Odontologica Scandinavica
Vol/bind	53
Udgave nummer	10
Sider (fra-til)	1440-1445
Antal sider	6
ISSN	0001-6357
DOI	https://doi.org/10.3109/0284186X.2014.921727
Status	Udgivet - 1 okt. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.3109/0284186X.2014.921727

Citationsformater

Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer. / Tuxen, Malgorzata K; Cold, Soeren; Tange, Ulla B et al.

I: Acta Odontologica Scandinavica, Bind 53, Nr. 10, 01.10.2014, s. 1440-1445.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

@article{ae96f330de5a475fb6856e416f8af874,

title = "Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer",

keywords = "Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Feasibility Studies, Female, Humans, Middle Aged, Neoadjuvant Therapy, Polyethylene Glycols, Receptor, ErbB-2, Receptors, Estrogen, Sample Size, Taxoids",

author = "Tuxen, {Malgorzata K} and Soeren Cold and Tange, {Ulla B} and Eva Balslev and Nielsen, {Dorte L}",

year = "2014",

month = oct,

day = "1",

doi = "10.3109/0284186X.2014.921727",

language = "English",

volume = "53",

pages = "1440--1445",

journal = "Acta Odontologica Scandinavica",

issn = "0001-6357",

publisher = "Taylor & Francis",

number = "10",

}

TY - JOUR

T1 - Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

AU - Tuxen, Malgorzata K

AU - Cold, Soeren

AU - Tange, Ulla B

AU - Balslev, Eva

AU - Nielsen, Dorte L

PY - 2014/10/1

Y1 - 2014/10/1

KW - Adult

KW - Aged

KW - Antibodies, Monoclonal, Humanized

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Breast Neoplasms

KW - Cyclophosphamide

KW - Doxorubicin

KW - Drug Administration Schedule

KW - Feasibility Studies

KW - Female

KW - Humans

KW - Middle Aged

KW - Neoadjuvant Therapy

KW - Polyethylene Glycols

KW - Receptor, ErbB-2

KW - Receptors, Estrogen

KW - Sample Size

KW - Taxoids

U2 - 10.3109/0284186X.2014.921727

DO - 10.3109/0284186X.2014.921727

M3 - Comment/debate

C2 - 24991893

SN - 0001-6357

VL - 53

SP - 1440

EP - 1445

JO - Acta Odontologica Scandinavica

JF - Acta Odontologica Scandinavica

IS - 10

ER -